Nitazoxanide

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Broad-spectrum antibiotic with antiparasitic effect from the class of thiazolides. Effective against protozoa and probably also antivirally effective in the therapy of Hepatítis C.

IndicationThis section has been translated automatically.

Cryptosporidiosis; lambliasis. Approved in the U.S. for the treatment of diarrhea caused by Cryptosporidia (Cryptosporidium parvum) and Giardia lamblia in children 1-11 years of age, adolescents and adults. Not yet approved in Germany.

Dosage and method of useThis section has been translated automatically.

  • HIV-negative adolescents/adults: 2 times/day 500 mg p.o. for 3 days.
  • HIV-negative children: 2 times/day 100-200 mg p.o. for 3 days.

Undesirable effectsThis section has been translated automatically.

Rarely abdominal pain, diarrhea, vomiting, headache, yellow sclerae (reversible scleral icterus due to deposition of the active ingredient.

PreparationsThis section has been translated automatically.

Alinia; Cryptaz (not approved in Germany; can be obtained from the international pharmacy)

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer